Literature DB >> 16935316

Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.

Fabiola E Villanova1, Priscila M Andrade, Audrey Y Otsuka, Mariano T V Gomes, Elcio S Leal, Rodrigo A Castro, Manoel J B C Girão, Eddy Nishimura, Edmund C Baracat, Ismael D C G Silva.   

Abstract

Uterine leiomyoma is the most frequent pelvic tumor found in female genital tract. Some studies have suggested an association between single nucleotide polymorphisms (SNPs) in estrogen receptors genes with susceptibility in developing uterine leiomyoma. In this work, we estimated the frequency of two SNPs: one located in the intron 1 (rs9322331) and other in the exon 1 (rs17847075) of the estrogen receptor alpha (ESR1) gene in 125 women with uterine leiomyoma and 125 healthy women. To do this we used a PCR-RFLP method with MspI and HaeIII restriction enzymes to respectively detect C/T SNPs in the intron 1 and in the exon 1 of ESR1. To our knowledge this is the first study aimed to investigate the association of ESR1 SNPs with the risk of developing uterine leiomyoma in Brazilian women. Our results showed that the allele frequencies of the exon 1 and the intron 1 of the ESR1 gene did not differ between cases and controls (P = 0.325 and 0.175, respectively). Furthermore, our findings provided little support for the association of these SNPs on ESR1 with leiomyoma. However, we found that the SNP in the intron 1 of the ESR1 gene was underrepresented in the Brazilian female population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935316     DOI: 10.1016/j.steroids.2006.07.005

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  14 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  The associations between the polymorphisms of the ER-α gene and the risk of uterine leiomyoma (ULM).

Authors:  Yi Feng; Xiaojuan Lin; Shengtao Zhou; Ning Xu; Tao Yi; Xia Zhao
Journal:  Tumour Biol       Date:  2013-06-09

3.  Association of FAS A-670G Polymorphism and Risk of Uterine Leiomyoma in a Southeast Iranian Population.

Authors:  Abbas Mohammadpour-Gharehbagh; Saeedeh Salimi; Farshid Keshavarzi; Sepideh Zakerian; Mojtaba Sajadian; Mojgan Mokhtari
Journal:  Rep Biochem Mol Biol       Date:  2016-10

4.  Association of estrogen and progesterone receptor gene polymorphisms and their respective hormones in uterine leiomyomas.

Authors:  M Veronica; Altaf Ali; A Venkateshwari; D Mamata; Pratibha Nallari
Journal:  Tumour Biol       Date:  2015-12-29

5.  The haplotypes GCA and ACA in ESR1 gene are associated with the susceptibility of recurrent spontaneous abortion (RSA) in Chinese Han: A case-control study and meta-analysis.

Authors:  Liang Tang; Qin Xiang; Ju Xiang; Jianming Li
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

Review 6.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

7.  Estrogen receptor alpha polymorphism is associated with pelvic organ prolapse risk.

Authors:  Huey-Yi Chen; Ya-Wen Chung; Wei-Yong Lin; Wei-Chi Chen; Fuu-Jen Tsai; Chang-Hai Tsai
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-04-03

8.  CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.

Authors:  Yi Ye; Xiao Cheng; Hai-Bo Luo; Li Liu; Ying-Bi Li; Yi-Ping Hou
Journal:  J Assist Reprod Genet       Date:  2008-09-02       Impact factor: 3.412

9.  Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.

Authors:  Qun Pan; Xiaoping Luo; Nasser Chegini
Journal:  J Cell Mol Med       Date:  2007-12-20       Impact factor: 5.310

10.  microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.

Authors:  Qun Pan; Xiaoping Luo; Nasser Chegini
Journal:  Mol Hum Reprod       Date:  2009-11-11       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.